nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—ABCB1—Desloratadine—allergic rhinitis	0.0635	0.107	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Hydrocortisone—allergic rhinitis	0.0415	0.0701	CbGbCtD
Sirolimus—CYP3A7—Hydrocortisone—allergic rhinitis	0.0415	0.0701	CbGbCtD
Sirolimus—CYP3A4—Flunisolide—allergic rhinitis	0.038	0.0642	CbGbCtD
Sirolimus—ABCB1—Loratadine—allergic rhinitis	0.0365	0.0615	CbGbCtD
Sirolimus—CYP3A4—Olopatadine—allergic rhinitis	0.0358	0.0603	CbGbCtD
Sirolimus—ABCB1—Methylprednisolone—allergic rhinitis	0.0333	0.0563	CbGbCtD
Sirolimus—CYP3A5—Hydrocortisone—allergic rhinitis	0.0312	0.0526	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Dexamethasone—allergic rhinitis	0.0258	0.0436	CbGbCtD
Sirolimus—CYP3A7—Dexamethasone—allergic rhinitis	0.0258	0.0436	CbGbCtD
Sirolimus—CYP3A4—Loratadine—allergic rhinitis	0.0218	0.0369	CbGbCtD
Sirolimus—CYP3A4—Montelukast—allergic rhinitis	0.0218	0.0369	CbGbCtD
Sirolimus—ABCB1—Betamethasone—allergic rhinitis	0.0217	0.0366	CbGbCtD
Sirolimus—ABCB1—Prednisolone—allergic rhinitis	0.0214	0.0361	CbGbCtD
Sirolimus—ABCB1—Hydrocortisone—allergic rhinitis	0.0203	0.0342	CbGbCtD
Sirolimus—CYP3A4—Methylprednisolone—allergic rhinitis	0.02	0.0337	CbGbCtD
Sirolimus—CYP3A5—Dexamethasone—allergic rhinitis	0.0194	0.0327	CbGbCtD
Sirolimus—CYP3A4—Triamcinolone—allergic rhinitis	0.0151	0.0255	CbGbCtD
Sirolimus—CYP3A4—Betamethasone—allergic rhinitis	0.013	0.0219	CbGbCtD
Sirolimus—CYP3A4—Prednisolone—allergic rhinitis	0.0128	0.0216	CbGbCtD
Sirolimus—ABCB1—Dexamethasone—allergic rhinitis	0.0126	0.0213	CbGbCtD
Sirolimus—CYP3A4—Hydrocortisone—allergic rhinitis	0.0121	0.0205	CbGbCtD
Sirolimus—CYP3A4—Dexamethasone—allergic rhinitis	0.00755	0.0128	CbGbCtD
Sirolimus—EIF4E—respiratory system—allergic rhinitis	0.00698	0.128	CbGeAlD
Sirolimus—FGF2—eye—allergic rhinitis	0.00389	0.0713	CbGeAlD
Sirolimus—EIF4E—lung—allergic rhinitis	0.0037	0.0679	CbGeAlD
Sirolimus—FGF2—bronchus—allergic rhinitis	0.0035	0.0642	CbGeAlD
Sirolimus—FGF2—trachea—allergic rhinitis	0.00314	0.0576	CbGeAlD
Sirolimus—MTOR—TSLP Signaling Pathway—TSLP—allergic rhinitis	0.00284	0.0638	CbGpPWpGaD
Sirolimus—MTOR—respiratory system—allergic rhinitis	0.0027	0.0495	CbGeAlD
Sirolimus—MTOR—eye—allergic rhinitis	0.00247	0.0452	CbGeAlD
Sirolimus—FKBP1A—respiratory system—allergic rhinitis	0.00243	0.0445	CbGeAlD
Sirolimus—FGF2—lung—allergic rhinitis	0.00226	0.0414	CbGeAlD
Sirolimus—MTOR—epithelium—allergic rhinitis	0.00226	0.0414	CbGeAlD
Sirolimus—FKBP1A—eye—allergic rhinitis	0.00222	0.0407	CbGeAlD
Sirolimus—MTOR—skin of body—allergic rhinitis	0.00215	0.0393	CbGeAlD
Sirolimus—FKBP1A—epithelium—allergic rhinitis	0.00203	0.0372	CbGeAlD
Sirolimus—FKBP1A—bronchus—allergic rhinitis	0.002	0.0366	CbGeAlD
Sirolimus—FKBP1A—skin of body—allergic rhinitis	0.00193	0.0354	CbGeAlD
Sirolimus—SLC47A1—eye—allergic rhinitis	0.00191	0.035	CbGeAlD
Sirolimus—FKBP1A—trachea—allergic rhinitis	0.00179	0.0329	CbGeAlD
Sirolimus—MTOR—lung—allergic rhinitis	0.00143	0.0263	CbGeAlD
Sirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.00132	0.0297	CbGpPWpGaD
Sirolimus—FKBP1A—lung—allergic rhinitis	0.00129	0.0236	CbGeAlD
Sirolimus—MTOR—Type II diabetes mellitus—ADIPOQ—allergic rhinitis	0.00126	0.0283	CbGpPWpGaD
Sirolimus—MTOR—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.00125	0.028	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—SMAD3—allergic rhinitis	0.00121	0.0271	CbGpPWpGaD
Sirolimus—SLC47A1—lung—allergic rhinitis	0.00111	0.0203	CbGeAlD
Sirolimus—CYP3A5—respiratory system—allergic rhinitis	0.00106	0.0194	CbGeAlD
Sirolimus—MTOR—TSLP Signaling Pathway—CCL11—allergic rhinitis	0.00105	0.0236	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFB1—allergic rhinitis	0.000892	0.02	CbGpPWpGaD
Sirolimus—MTOR—IL4-mediated signaling events—CCL11—allergic rhinitis	0.000844	0.0189	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling—SMAD3—allergic rhinitis	0.000821	0.0184	CbGpPWpGaD
Sirolimus—EIF4E—Validated targets of C-MYC transcriptional activation—SMAD3—allergic rhinitis	0.000801	0.018	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—SMAD3—allergic rhinitis	0.000796	0.0179	CbGpPWpGaD
Sirolimus—EIF4E—Interferon Signaling—HLA-G—allergic rhinitis	0.000768	0.0172	CbGpPWpGaD
Sirolimus—FGF2—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000762	0.0171	CbGpPWpGaD
Sirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—SMAD3—allergic rhinitis	0.000717	0.0161	CbGpPWpGaD
Sirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SMAD3—allergic rhinitis	0.000647	0.0145	CbGpPWpGaD
Sirolimus—EIF4E—Structural Pathway of Interleukin 1 (IL-1)—NFKB1—allergic rhinitis	0.000617	0.0138	CbGpPWpGaD
Sirolimus—FKBP1A—ALK1 signaling events—TGFB1—allergic rhinitis	0.000605	0.0136	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—PFN2—allergic rhinitis	0.000584	0.0131	CbGpPWpGaD
Sirolimus—MTOR—IL4-mediated signaling events—IL5—allergic rhinitis	0.00057	0.0128	CbGpPWpGaD
Sirolimus—FGF2—Syndecan interactions—TGFB1—allergic rhinitis	0.000566	0.0127	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000566	0.0127	CbGpPWpGaD
Sirolimus—ABCB1—respiratory system—allergic rhinitis	0.000562	0.0103	CbGeAlD
Sirolimus—CYP3A5—lung—allergic rhinitis	0.000561	0.0103	CbGeAlD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000513	0.0115	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFB1—allergic rhinitis	0.000513	0.0115	CbGpPWpGaD
Sirolimus—MTOR—AMPK Signaling—ADIPOQ—allergic rhinitis	0.000507	0.0114	CbGpPWpGaD
Sirolimus—EIF4E—Interferon Signaling—HLA-DQB1—allergic rhinitis	0.00048	0.0107	CbGpPWpGaD
Sirolimus—ABCB1—epithelium—allergic rhinitis	0.000469	0.00861	CbGeAlD
Sirolimus—FGF2—Glypican 1 network—TGFB1—allergic rhinitis	0.000459	0.0103	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—IL4—allergic rhinitis	0.000431	0.00965	CbGpPWpGaD
Sirolimus—EIF4E—Leptin signaling pathway—NFKB1—allergic rhinitis	0.000424	0.00951	CbGpPWpGaD
Sirolimus—MTOR—IL4-mediated signaling events—IL10—allergic rhinitis	0.000417	0.00934	CbGpPWpGaD
Sirolimus—MTOR—IL12-mediated signaling events—IL4—allergic rhinitis	0.000416	0.00933	CbGpPWpGaD
Sirolimus—ABCB1—trachea—allergic rhinitis	0.000415	0.00761	CbGeAlD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000414	0.00927	CbGpPWpGaD
Sirolimus—MTOR—Costimulation by the CD28 family—HLA-DQB1—allergic rhinitis	0.00041	0.00919	CbGpPWpGaD
Sirolimus—MTOR—IL4-mediated signaling events—IL4—allergic rhinitis	0.000405	0.00909	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—NFKB1—allergic rhinitis	0.000405	0.00907	CbGpPWpGaD
Sirolimus—MTOR—Regulation of Telomerase—SMAD3—allergic rhinitis	0.000373	0.00835	CbGpPWpGaD
Sirolimus—MTOR—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.000354	0.00794	CbGpPWpGaD
Sirolimus—EIF4E—Interferon Signaling—ICAM1—allergic rhinitis	0.00035	0.00784	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling—TGFB1—allergic rhinitis	0.000348	0.00779	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000342	0.00767	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—TGFB1—allergic rhinitis	0.000337	0.00756	CbGpPWpGaD
Sirolimus—FGF2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—allergic rhinitis	0.000326	0.00731	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.00032	0.00718	CbGpPWpGaD
Sirolimus—FGF2—Non-integrin membrane-ECM interactions—TGFB1—allergic rhinitis	0.000313	0.007	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—MS4A2—allergic rhinitis	0.00031	0.00696	CbGpPWpGaD
Sirolimus—MTOR—IL2 signaling events mediated by PI3K—NFKB1—allergic rhinitis	0.000308	0.00691	CbGpPWpGaD
Sirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—allergic rhinitis	0.000304	0.0068	CbGpPWpGaD
Sirolimus—FGF2—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000302	0.00678	CbGpPWpGaD
Sirolimus—ABCB1—lung—allergic rhinitis	0.000298	0.00547	CbGeAlD
Sirolimus—FGF2—Innate Immune System—MS4A2—allergic rhinitis	0.000296	0.00664	CbGpPWpGaD
Sirolimus—FGF2—Differentiation Pathway—TGFB1—allergic rhinitis	0.000281	0.0063	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	0.000276	0.00619	CbGpPWpGaD
Sirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFB1—allergic rhinitis	0.000274	0.00614	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	0.000263	0.0059	CbGpPWpGaD
Sirolimus—FGF2—Cardiac Progenitor Differentiation—TGFB1—allergic rhinitis	0.000259	0.00582	CbGpPWpGaD
Sirolimus—MTOR—TSLP Signaling Pathway—NFKB1—allergic rhinitis	0.000254	0.0057	CbGpPWpGaD
Sirolimus—FGF2—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000252	0.00565	CbGpPWpGaD
Sirolimus—EIF4E—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000252	0.00565	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	0.000251	0.00562	CbGpPWpGaD
Sirolimus—MTOR—IL12-mediated signaling events—CD4—allergic rhinitis	0.000243	0.00545	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL13—allergic rhinitis	0.000236	0.00529	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000234	0.00524	CbGpPWpGaD
Sirolimus—MTOR—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000224	0.00503	CbGpPWpGaD
Sirolimus—MTOR—RANKL/RANK Signaling Pathway—NFKB1—allergic rhinitis	0.000224	0.00503	CbGpPWpGaD
Sirolimus—FGF2—Endochondral Ossification—TGFB1—allergic rhinitis	0.000223	0.005	CbGpPWpGaD
Sirolimus—MTOR—Costimulation by the CD28 family—CD4—allergic rhinitis	0.00022	0.00493	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—MS4A2—allergic rhinitis	0.00022	0.00493	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	0.000217	0.00487	CbGpPWpGaD
Sirolimus—FGF2—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.000215	0.00483	CbGpPWpGaD
Sirolimus—MTOR—IL12-mediated signaling events—NFKB1—allergic rhinitis	0.000209	0.00469	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL5—allergic rhinitis	0.000202	0.00453	CbGpPWpGaD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	0.000196	0.0044	CbGpPWpGaD
Sirolimus—MTOR—Regulation of Telomerase—NFKB1—allergic rhinitis	0.000189	0.00424	CbGpPWpGaD
Sirolimus—MTOR—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000187	0.00419	CbGpPWpGaD
Sirolimus—FGF2—Neural Crest Differentiation—NFKB1—allergic rhinitis	0.000186	0.00417	CbGpPWpGaD
Sirolimus—MTOR—CXCR4-mediated signaling events—CD4—allergic rhinitis	0.000186	0.00416	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—TGFB1—allergic rhinitis	0.00018	0.00404	CbGpPWpGaD
Sirolimus—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	0.000179	0.00402	CbGpPWpGaD
Sirolimus—MTOR—Leptin signaling pathway—NFKB1—allergic rhinitis	0.000175	0.00392	CbGpPWpGaD
Sirolimus—FGF2—Immune System—MS4A2—allergic rhinitis	0.000172	0.00387	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—PTGDR2—allergic rhinitis	0.000171	0.00382	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—HLA-G—allergic rhinitis	0.000168	0.00376	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000164	0.00368	CbGpPWpGaD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.00016	0.00358	CbGpPWpGaD
Sirolimus—MTOR—Regulation of Telomerase—TGFB1—allergic rhinitis	0.000158	0.00354	CbGpPWpGaD
Sirolimus—Asthenia—Montelukast—allergic rhinitis	0.000157	0.000511	CcSEcCtD
Sirolimus—Rhinitis—Methylprednisolone—allergic rhinitis	0.000157	0.00051	CcSEcCtD
Sirolimus—Haemorrhage—Triamcinolone—allergic rhinitis	0.000157	0.000509	CcSEcCtD
Sirolimus—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000157	0.000508	CcSEcCtD
Sirolimus—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000156	0.00351	CbGpPWpGaD
Sirolimus—Hallucination—Methylprednisolone—allergic rhinitis	0.000156	0.000506	CcSEcCtD
Sirolimus—Pharyngitis—Triamcinolone—allergic rhinitis	0.000156	0.000506	CcSEcCtD
Sirolimus—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.000156	0.000505	CcSEcCtD
Sirolimus—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.000156	0.000505	CcSEcCtD
Sirolimus—Nausea—Cetirizine—allergic rhinitis	0.000155	0.000504	CcSEcCtD
Sirolimus—Pruritus—Montelukast—allergic rhinitis	0.000155	0.000504	CcSEcCtD
Sirolimus—Conjunctivitis—Dexamethasone—allergic rhinitis	0.000154	0.0005	CcSEcCtD
Sirolimus—Conjunctivitis—Betamethasone—allergic rhinitis	0.000154	0.0005	CcSEcCtD
Sirolimus—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000154	0.000499	CcSEcCtD
Sirolimus—FGF2—Adaptive Immune System—HLA-G—allergic rhinitis	0.000154	0.00344	CbGpPWpGaD
Sirolimus—Nausea—Flunisolide—allergic rhinitis	0.000153	0.000496	CcSEcCtD
Sirolimus—Visual impairment—Methylprednisolone—allergic rhinitis	0.000151	0.00049	CcSEcCtD
Sirolimus—Immune system disorder—Hydrocortisone—allergic rhinitis	0.000151	0.000489	CcSEcCtD
Sirolimus—Diarrhoea—Montelukast—allergic rhinitis	0.00015	0.000487	CcSEcCtD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000148	0.00332	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL10—allergic rhinitis	0.000148	0.00331	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000147	0.0033	CbGpPWpGaD
Sirolimus—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000145	0.000472	CcSEcCtD
Sirolimus—Malnutrition—Hydrocortisone—allergic rhinitis	0.000145	0.000471	CcSEcCtD
Sirolimus—Dizziness—Montelukast—allergic rhinitis	0.000145	0.000471	CcSEcCtD
Sirolimus—ABCB1—Allograft Rejection—IL4—allergic rhinitis	0.000144	0.00322	CbGpPWpGaD
Sirolimus—Haemoglobin—Dexamethasone—allergic rhinitis	0.000143	0.000465	CcSEcCtD
Sirolimus—Haemoglobin—Betamethasone—allergic rhinitis	0.000143	0.000465	CcSEcCtD
Sirolimus—Haemorrhage—Betamethasone—allergic rhinitis	0.000143	0.000462	CcSEcCtD
Sirolimus—Haemorrhage—Dexamethasone—allergic rhinitis	0.000143	0.000462	CcSEcCtD
Sirolimus—Angiopathy—Methylprednisolone—allergic rhinitis	0.000142	0.000461	CcSEcCtD
Sirolimus—Hallucination—Betamethasone—allergic rhinitis	0.000142	0.00046	CcSEcCtD
Sirolimus—Hallucination—Dexamethasone—allergic rhinitis	0.000142	0.00046	CcSEcCtD
Sirolimus—Immune system disorder—Methylprednisolone—allergic rhinitis	0.000142	0.000459	CcSEcCtD
Sirolimus—FGF2—Developmental Biology—ADIPOQ—allergic rhinitis	0.000141	0.00317	CbGpPWpGaD
Sirolimus—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000141	0.000458	CcSEcCtD
Sirolimus—Vomiting—Montelukast—allergic rhinitis	0.00014	0.000453	CcSEcCtD
Sirolimus—Rash—Montelukast—allergic rhinitis	0.000138	0.000449	CcSEcCtD
Sirolimus—Dermatitis—Montelukast—allergic rhinitis	0.000138	0.000448	CcSEcCtD
Sirolimus—Ill-defined disorder—Prednisolone—allergic rhinitis	0.000138	0.000447	CcSEcCtD
Sirolimus—Headache—Montelukast—allergic rhinitis	0.000137	0.000446	CcSEcCtD
Sirolimus—Visual impairment—Dexamethasone—allergic rhinitis	0.000137	0.000445	CcSEcCtD
Sirolimus—Visual impairment—Betamethasone—allergic rhinitis	0.000137	0.000445	CcSEcCtD
Sirolimus—Malnutrition—Methylprednisolone—allergic rhinitis	0.000136	0.000442	CcSEcCtD
Sirolimus—FGF2—Extracellular matrix organization—ICAM1—allergic rhinitis	0.000136	0.00305	CbGpPWpGaD
Sirolimus—Angioedema—Prednisolone—allergic rhinitis	0.000136	0.000441	CcSEcCtD
Sirolimus—EIF4E—Immune System—IL5—allergic rhinitis	0.000135	0.00303	CbGpPWpGaD
Sirolimus—Ill-defined disorder—Hydrocortisone—allergic rhinitis	0.000135	0.000437	CcSEcCtD
Sirolimus—Malaise—Prednisolone—allergic rhinitis	0.000134	0.000435	CcSEcCtD
Sirolimus—EIF4E—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000134	0.003	CbGpPWpGaD
Sirolimus—Syncope—Prednisolone—allergic rhinitis	0.000133	0.000432	CcSEcCtD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	0.000133	0.00299	CbGpPWpGaD
Sirolimus—Angioedema—Hydrocortisone—allergic rhinitis	0.000133	0.00043	CcSEcCtD
Sirolimus—Back pain—Triamcinolone—allergic rhinitis	0.000132	0.000429	CcSEcCtD
Sirolimus—Malaise—Hydrocortisone—allergic rhinitis	0.000131	0.000425	CcSEcCtD
Sirolimus—Loss of consciousness—Prednisolone—allergic rhinitis	0.000131	0.000424	CcSEcCtD
Sirolimus—Nausea—Montelukast—allergic rhinitis	0.00013	0.000423	CcSEcCtD
Sirolimus—Syncope—Hydrocortisone—allergic rhinitis	0.00013	0.000422	CcSEcCtD
Sirolimus—Angiopathy—Dexamethasone—allergic rhinitis	0.000129	0.000419	CcSEcCtD
Sirolimus—Angiopathy—Betamethasone—allergic rhinitis	0.000129	0.000419	CcSEcCtD
Sirolimus—EIF4E—Signaling Pathways—CCL11—allergic rhinitis	0.000129	0.0029	CbGpPWpGaD
Sirolimus—Hypertension—Prednisolone—allergic rhinitis	0.000128	0.000416	CcSEcCtD
Sirolimus—MTOR—Immune System—MS4A2—allergic rhinitis	0.000128	0.00287	CbGpPWpGaD
Sirolimus—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.000128	0.000414	CcSEcCtD
Sirolimus—Ill-defined disorder—Triamcinolone—allergic rhinitis	0.000127	0.000411	CcSEcCtD
Sirolimus—Ill-defined disorder—Methylprednisolone—allergic rhinitis	0.000127	0.000411	CcSEcCtD
Sirolimus—Hypertension—Hydrocortisone—allergic rhinitis	0.000125	0.000407	CcSEcCtD
Sirolimus—FKBP1A—Signaling Pathways—PTGDR2—allergic rhinitis	0.000125	0.0028	CbGpPWpGaD
Sirolimus—Discomfort—Prednisolone—allergic rhinitis	0.000125	0.000406	CcSEcCtD
Sirolimus—Angioedema—Triamcinolone—allergic rhinitis	0.000125	0.000405	CcSEcCtD
Sirolimus—Angioedema—Methylprednisolone—allergic rhinitis	0.000125	0.000404	CcSEcCtD
Sirolimus—FGF2—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000124	0.00279	CbGpPWpGaD
Sirolimus—Myalgia—Hydrocortisone—allergic rhinitis	0.000124	0.000401	CcSEcCtD
Sirolimus—Malaise—Triamcinolone—allergic rhinitis	0.000123	0.0004	CcSEcCtD
Sirolimus—Anxiety—Hydrocortisone—allergic rhinitis	0.000123	0.0004	CcSEcCtD
Sirolimus—Malaise—Methylprednisolone—allergic rhinitis	0.000123	0.000399	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000123	0.000398	CcSEcCtD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.000123	0.00275	CbGpPWpGaD
Sirolimus—Syncope—Triamcinolone—allergic rhinitis	0.000123	0.000398	CcSEcCtD
Sirolimus—Syncope—Methylprednisolone—allergic rhinitis	0.000122	0.000397	CcSEcCtD
Sirolimus—Discomfort—Hydrocortisone—allergic rhinitis	0.000122	0.000396	CcSEcCtD
Sirolimus—Oedema—Prednisolone—allergic rhinitis	0.000121	0.000394	CcSEcCtD
Sirolimus—Anaphylactic shock—Prednisolone—allergic rhinitis	0.000121	0.000394	CcSEcCtD
Sirolimus—Loss of consciousness—Triamcinolone—allergic rhinitis	0.00012	0.00039	CcSEcCtD
Sirolimus—Loss of consciousness—Methylprednisolone—allergic rhinitis	0.00012	0.000389	CcSEcCtD
Sirolimus—Shock—Prednisolone—allergic rhinitis	0.000119	0.000387	CcSEcCtD
Sirolimus—Cough—Triamcinolone—allergic rhinitis	0.000119	0.000387	CcSEcCtD
Sirolimus—FGF2—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000119	0.00266	CbGpPWpGaD
Sirolimus—Oedema—Hydrocortisone—allergic rhinitis	0.000119	0.000384	CcSEcCtD
Sirolimus—Anaphylactic shock—Hydrocortisone—allergic rhinitis	0.000119	0.000384	CcSEcCtD
Sirolimus—Tachycardia—Prednisolone—allergic rhinitis	0.000118	0.000384	CcSEcCtD
Sirolimus—Hypertension—Triamcinolone—allergic rhinitis	0.000118	0.000383	CcSEcCtD
Sirolimus—Hypertension—Methylprednisolone—allergic rhinitis	0.000118	0.000382	CcSEcCtD
Sirolimus—Infection—Hydrocortisone—allergic rhinitis	0.000118	0.000382	CcSEcCtD
Sirolimus—Hyperhidrosis—Prednisolone—allergic rhinitis	0.000117	0.00038	CcSEcCtD
Sirolimus—Shock—Hydrocortisone—allergic rhinitis	0.000117	0.000378	CcSEcCtD
Sirolimus—Myalgia—Triamcinolone—allergic rhinitis	0.000116	0.000378	CcSEcCtD
Sirolimus—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000116	0.000377	CcSEcCtD
Sirolimus—Myalgia—Methylprednisolone—allergic rhinitis	0.000116	0.000377	CcSEcCtD
Sirolimus—Arthralgia—Methylprednisolone—allergic rhinitis	0.000116	0.000377	CcSEcCtD
Sirolimus—Anxiety—Methylprednisolone—allergic rhinitis	0.000116	0.000375	CcSEcCtD
Sirolimus—Tachycardia—Hydrocortisone—allergic rhinitis	0.000116	0.000375	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000115	0.000374	CcSEcCtD
Sirolimus—Skin disorder—Hydrocortisone—allergic rhinitis	0.000115	0.000373	CcSEcCtD
Sirolimus—Ill-defined disorder—Dexamethasone—allergic rhinitis	0.000115	0.000373	CcSEcCtD
Sirolimus—Ill-defined disorder—Betamethasone—allergic rhinitis	0.000115	0.000373	CcSEcCtD
Sirolimus—Discomfort—Triamcinolone—allergic rhinitis	0.000115	0.000373	CcSEcCtD
Sirolimus—Discomfort—Methylprednisolone—allergic rhinitis	0.000115	0.000372	CcSEcCtD
Sirolimus—Hyperhidrosis—Hydrocortisone—allergic rhinitis	0.000115	0.000372	CcSEcCtD
Sirolimus—MTOR—Adaptive Immune System—HLA-G—allergic rhinitis	0.000114	0.00255	CbGpPWpGaD
Sirolimus—Angioedema—Betamethasone—allergic rhinitis	0.000113	0.000368	CcSEcCtD
Sirolimus—Angioedema—Dexamethasone—allergic rhinitis	0.000113	0.000368	CcSEcCtD
Sirolimus—Anorexia—Hydrocortisone—allergic rhinitis	0.000113	0.000366	CcSEcCtD
Sirolimus—Confusional state—Methylprednisolone—allergic rhinitis	0.000112	0.000364	CcSEcCtD
Sirolimus—Malaise—Dexamethasone—allergic rhinitis	0.000112	0.000363	CcSEcCtD
Sirolimus—Malaise—Betamethasone—allergic rhinitis	0.000112	0.000363	CcSEcCtD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000112	0.0025	CbGpPWpGaD
Sirolimus—Anaphylactic shock—Triamcinolone—allergic rhinitis	0.000112	0.000362	CcSEcCtD
Sirolimus—Oedema—Triamcinolone—allergic rhinitis	0.000112	0.000362	CcSEcCtD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	0.000111	0.0025	CbGpPWpGaD
Sirolimus—Anaphylactic shock—Methylprednisolone—allergic rhinitis	0.000111	0.000361	CcSEcCtD
Sirolimus—Syncope—Betamethasone—allergic rhinitis	0.000111	0.000361	CcSEcCtD
Sirolimus—Syncope—Dexamethasone—allergic rhinitis	0.000111	0.000361	CcSEcCtD
Sirolimus—Infection—Triamcinolone—allergic rhinitis	0.000111	0.00036	CcSEcCtD
Sirolimus—Hypotension—Hydrocortisone—allergic rhinitis	0.000111	0.000359	CcSEcCtD
Sirolimus—Infection—Methylprednisolone—allergic rhinitis	0.000111	0.000359	CcSEcCtD
Sirolimus—FGF2—B Cell Activation—NFKB1—allergic rhinitis	0.00011	0.00246	CbGpPWpGaD
Sirolimus—Shock—Triamcinolone—allergic rhinitis	0.00011	0.000356	CcSEcCtD
Sirolimus—Insomnia—Prednisolone—allergic rhinitis	0.00011	0.000356	CcSEcCtD
Sirolimus—Shock—Methylprednisolone—allergic rhinitis	0.00011	0.000355	CcSEcCtD
Sirolimus—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000109	0.000354	CcSEcCtD
Sirolimus—Loss of consciousness—Dexamethasone—allergic rhinitis	0.000109	0.000354	CcSEcCtD
Sirolimus—Loss of consciousness—Betamethasone—allergic rhinitis	0.000109	0.000354	CcSEcCtD
Sirolimus—Paraesthesia—Prednisolone—allergic rhinitis	0.000109	0.000353	CcSEcCtD
Sirolimus—Tachycardia—Triamcinolone—allergic rhinitis	0.000109	0.000353	CcSEcCtD
Sirolimus—Tachycardia—Methylprednisolone—allergic rhinitis	0.000109	0.000352	CcSEcCtD
Sirolimus—Skin disorder—Methylprednisolone—allergic rhinitis	0.000108	0.000351	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000108	0.00035	CcSEcCtD
Sirolimus—Hyperhidrosis—Triamcinolone—allergic rhinitis	0.000108	0.00035	CcSEcCtD
Sirolimus—Hyperhidrosis—Methylprednisolone—allergic rhinitis	0.000108	0.000349	CcSEcCtD
Sirolimus—Insomnia—Hydrocortisone—allergic rhinitis	0.000107	0.000348	CcSEcCtD
Sirolimus—Hypertension—Betamethasone—allergic rhinitis	0.000107	0.000347	CcSEcCtD
Sirolimus—Hypertension—Dexamethasone—allergic rhinitis	0.000107	0.000347	CcSEcCtD
Sirolimus—Paraesthesia—Hydrocortisone—allergic rhinitis	0.000106	0.000345	CcSEcCtD
Sirolimus—Myalgia—Betamethasone—allergic rhinitis	0.000106	0.000343	CcSEcCtD
Sirolimus—Myalgia—Dexamethasone—allergic rhinitis	0.000106	0.000343	CcSEcCtD
Sirolimus—Anxiety—Betamethasone—allergic rhinitis	0.000105	0.000341	CcSEcCtD
Sirolimus—Anxiety—Dexamethasone—allergic rhinitis	0.000105	0.000341	CcSEcCtD
Sirolimus—EIF4E—Immune System—HLA-DQB1—allergic rhinitis	0.000105	0.00234	CbGpPWpGaD
Sirolimus—Discomfort—Dexamethasone—allergic rhinitis	0.000104	0.000338	CcSEcCtD
Sirolimus—Discomfort—Betamethasone—allergic rhinitis	0.000104	0.000338	CcSEcCtD
Sirolimus—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000104	0.000338	CcSEcCtD
Sirolimus—Hypotension—Methylprednisolone—allergic rhinitis	0.000104	0.000337	CcSEcCtD
Sirolimus—MTOR—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000104	0.00233	CbGpPWpGaD
Sirolimus—Pain—Prednisolone—allergic rhinitis	0.000104	0.000337	CcSEcCtD
Sirolimus—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000103	0.000334	CcSEcCtD
Sirolimus—FGF2—Developmental Biology—SMAD3—allergic rhinitis	0.000103	0.0023	CbGpPWpGaD
Sirolimus—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000102	0.000332	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000102	0.00033	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000101	0.000329	CcSEcCtD
Sirolimus—Pain—Hydrocortisone—allergic rhinitis	0.000101	0.000329	CcSEcCtD
Sirolimus—Oedema—Dexamethasone—allergic rhinitis	0.000101	0.000328	CcSEcCtD
Sirolimus—Oedema—Betamethasone—allergic rhinitis	0.000101	0.000328	CcSEcCtD
Sirolimus—Anaphylactic shock—Dexamethasone—allergic rhinitis	0.000101	0.000328	CcSEcCtD
Sirolimus—Anaphylactic shock—Betamethasone—allergic rhinitis	0.000101	0.000328	CcSEcCtD
Sirolimus—Insomnia—Triamcinolone—allergic rhinitis	0.000101	0.000327	CcSEcCtD
Sirolimus—Insomnia—Methylprednisolone—allergic rhinitis	0.000101	0.000327	CcSEcCtD
Sirolimus—Infection—Betamethasone—allergic rhinitis	0.000101	0.000326	CcSEcCtD
Sirolimus—Infection—Dexamethasone—allergic rhinitis	0.000101	0.000326	CcSEcCtD
Sirolimus—Paraesthesia—Triamcinolone—allergic rhinitis	0.0001	0.000325	CcSEcCtD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.0001	0.00224	CbGpPWpGaD
Sirolimus—Feeling abnormal—Prednisolone—allergic rhinitis	0.0001	0.000324	CcSEcCtD
Sirolimus—Paraesthesia—Methylprednisolone—allergic rhinitis	0.0001	0.000324	CcSEcCtD
Sirolimus—Shock—Dexamethasone—allergic rhinitis	9.96e-05	0.000323	CcSEcCtD
Sirolimus—Shock—Betamethasone—allergic rhinitis	9.96e-05	0.000323	CcSEcCtD
Sirolimus—Dyspnoea—Triamcinolone—allergic rhinitis	9.95e-05	0.000323	CcSEcCtD
Sirolimus—Nervous system disorder—Betamethasone—allergic rhinitis	9.93e-05	0.000322	CcSEcCtD
Sirolimus—Nervous system disorder—Dexamethasone—allergic rhinitis	9.93e-05	0.000322	CcSEcCtD
Sirolimus—Thrombocytopenia—Betamethasone—allergic rhinitis	9.91e-05	0.000322	CcSEcCtD
Sirolimus—Thrombocytopenia—Dexamethasone—allergic rhinitis	9.91e-05	0.000322	CcSEcCtD
Sirolimus—Tachycardia—Dexamethasone—allergic rhinitis	9.88e-05	0.00032	CcSEcCtD
Sirolimus—Tachycardia—Betamethasone—allergic rhinitis	9.88e-05	0.00032	CcSEcCtD
Sirolimus—Dyspepsia—Triamcinolone—allergic rhinitis	9.82e-05	0.000319	CcSEcCtD
Sirolimus—FKBP1A—Signaling Pathways—CYSLTR1—allergic rhinitis	9.82e-05	0.0022	CbGpPWpGaD
Sirolimus—Dyspepsia—Methylprednisolone—allergic rhinitis	9.8e-05	0.000318	CcSEcCtD
Sirolimus—Hyperhidrosis—Dexamethasone—allergic rhinitis	9.79e-05	0.000317	CcSEcCtD
Sirolimus—Hyperhidrosis—Betamethasone—allergic rhinitis	9.79e-05	0.000317	CcSEcCtD
Sirolimus—Feeling abnormal—Hydrocortisone—allergic rhinitis	9.77e-05	0.000317	CcSEcCtD
Sirolimus—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	9.69e-05	0.000314	CcSEcCtD
Sirolimus—Anorexia—Dexamethasone—allergic rhinitis	9.65e-05	0.000313	CcSEcCtD
Sirolimus—Anorexia—Betamethasone—allergic rhinitis	9.65e-05	0.000313	CcSEcCtD
Sirolimus—FGF2—Adaptive Immune System—HLA-DQB1—allergic rhinitis	9.58e-05	0.00215	CbGpPWpGaD
Sirolimus—Pain—Triamcinolone—allergic rhinitis	9.54e-05	0.000309	CcSEcCtD
Sirolimus—FKBP1A—Signaling Pathways—CCL11—allergic rhinitis	9.48e-05	0.00213	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PTGDR2—allergic rhinitis	9.48e-05	0.00213	CbGpPWpGaD
Sirolimus—Hypotension—Betamethasone—allergic rhinitis	9.46e-05	0.000307	CcSEcCtD
Sirolimus—Hypotension—Dexamethasone—allergic rhinitis	9.46e-05	0.000307	CcSEcCtD
Sirolimus—EIF4E—Gene Expression—SMAD3—allergic rhinitis	9.45e-05	0.00212	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TAC1—allergic rhinitis	9.39e-05	0.00211	CbGpPWpGaD
Sirolimus—Abdominal pain—Hydrocortisone—allergic rhinitis	9.37e-05	0.000304	CcSEcCtD
Sirolimus—Body temperature increased—Hydrocortisone—allergic rhinitis	9.37e-05	0.000304	CcSEcCtD
Sirolimus—FGF2—Immune System—HLA-G—allergic rhinitis	9.31e-05	0.00209	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	9.3e-05	0.00209	CbGpPWpGaD
Sirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	9.23e-05	0.00207	CbGpPWpGaD
Sirolimus—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	9.23e-05	0.000299	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	9.23e-05	0.000299	CcSEcCtD
Sirolimus—Feeling abnormal—Triamcinolone—allergic rhinitis	9.2e-05	0.000298	CcSEcCtD
Sirolimus—Feeling abnormal—Methylprednisolone—allergic rhinitis	9.18e-05	0.000298	CcSEcCtD
Sirolimus—Insomnia—Dexamethasone—allergic rhinitis	9.16e-05	0.000297	CcSEcCtD
Sirolimus—Insomnia—Betamethasone—allergic rhinitis	9.16e-05	0.000297	CcSEcCtD
Sirolimus—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	9.1e-05	0.000295	CcSEcCtD
Sirolimus—Paraesthesia—Dexamethasone—allergic rhinitis	9.09e-05	0.000295	CcSEcCtD
Sirolimus—Paraesthesia—Betamethasone—allergic rhinitis	9.09e-05	0.000295	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisolone—allergic rhinitis	8.94e-05	0.00029	CcSEcCtD
Sirolimus—Dyspepsia—Betamethasone—allergic rhinitis	8.91e-05	0.000289	CcSEcCtD
Sirolimus—Dyspepsia—Dexamethasone—allergic rhinitis	8.91e-05	0.000289	CcSEcCtD
Sirolimus—Body temperature increased—Triamcinolone—allergic rhinitis	8.82e-05	0.000286	CcSEcCtD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	8.81e-05	0.00197	CbGpPWpGaD
Sirolimus—Abdominal pain—Methylprednisolone—allergic rhinitis	8.8e-05	0.000285	CcSEcCtD
Sirolimus—Decreased appetite—Dexamethasone—allergic rhinitis	8.8e-05	0.000285	CcSEcCtD
Sirolimus—Decreased appetite—Betamethasone—allergic rhinitis	8.8e-05	0.000285	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	8.74e-05	0.000284	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Betamethasone—allergic rhinitis	8.74e-05	0.000284	CcSEcCtD
Sirolimus—EIF4E—Signaling Pathways—IL5—allergic rhinitis	8.73e-05	0.00196	CbGpPWpGaD
Sirolimus—Hypersensitivity—Hydrocortisone—allergic rhinitis	8.73e-05	0.000283	CcSEcCtD
Sirolimus—Pain—Dexamethasone—allergic rhinitis	8.66e-05	0.000281	CcSEcCtD
Sirolimus—Pain—Betamethasone—allergic rhinitis	8.66e-05	0.000281	CcSEcCtD
Sirolimus—Asthenia—Hydrocortisone—allergic rhinitis	8.5e-05	0.000276	CcSEcCtD
Sirolimus—Pruritus—Hydrocortisone—allergic rhinitis	8.38e-05	0.000272	CcSEcCtD
Sirolimus—Feeling abnormal—Betamethasone—allergic rhinitis	8.34e-05	0.000271	CcSEcCtD
Sirolimus—Feeling abnormal—Dexamethasone—allergic rhinitis	8.34e-05	0.000271	CcSEcCtD
Sirolimus—Gastrointestinal pain—Betamethasone—allergic rhinitis	8.28e-05	0.000269	CcSEcCtD
Sirolimus—Gastrointestinal pain—Dexamethasone—allergic rhinitis	8.28e-05	0.000269	CcSEcCtD
Sirolimus—Hypersensitivity—Triamcinolone—allergic rhinitis	8.22e-05	0.000267	CcSEcCtD
Sirolimus—Hypersensitivity—Methylprednisolone—allergic rhinitis	8.2e-05	0.000266	CcSEcCtD
Sirolimus—MTOR—B Cell Activation—NFKB1—allergic rhinitis	8.15e-05	0.00183	CbGpPWpGaD
Sirolimus—Diarrhoea—Hydrocortisone—allergic rhinitis	8.11e-05	0.000263	CcSEcCtD
Sirolimus—FGF2—Signaling by NGF—NFKB1—allergic rhinitis	8.09e-05	0.00181	CbGpPWpGaD
Sirolimus—Dizziness—Prednisolone—allergic rhinitis	8.02e-05	0.00026	CcSEcCtD
Sirolimus—Asthenia—Triamcinolone—allergic rhinitis	8.01e-05	0.00026	CcSEcCtD
Sirolimus—Body temperature increased—Betamethasone—allergic rhinitis	8e-05	0.00026	CcSEcCtD
Sirolimus—Abdominal pain—Dexamethasone—allergic rhinitis	8e-05	0.00026	CcSEcCtD
Sirolimus—Body temperature increased—Dexamethasone—allergic rhinitis	8e-05	0.00026	CcSEcCtD
Sirolimus—Abdominal pain—Betamethasone—allergic rhinitis	8e-05	0.00026	CcSEcCtD
Sirolimus—Asthenia—Methylprednisolone—allergic rhinitis	7.99e-05	0.000259	CcSEcCtD
Sirolimus—Pruritus—Triamcinolone—allergic rhinitis	7.9e-05	0.000256	CcSEcCtD
Sirolimus—Pruritus—Methylprednisolone—allergic rhinitis	7.88e-05	0.000255	CcSEcCtD
Sirolimus—Dizziness—Hydrocortisone—allergic rhinitis	7.84e-05	0.000254	CcSEcCtD
Sirolimus—Rash—Prednisolone—allergic rhinitis	7.65e-05	0.000248	CcSEcCtD
Sirolimus—Dermatitis—Prednisolone—allergic rhinitis	7.64e-05	0.000248	CcSEcCtD
Sirolimus—EIF4E—Immune System—ICAM1—allergic rhinitis	7.63e-05	0.00171	CbGpPWpGaD
Sirolimus—Diarrhoea—Methylprednisolone—allergic rhinitis	7.62e-05	0.000247	CcSEcCtD
Sirolimus—Headache—Prednisolone—allergic rhinitis	7.6e-05	0.000247	CcSEcCtD
Sirolimus—Vomiting—Hydrocortisone—allergic rhinitis	7.54e-05	0.000244	CcSEcCtD
Sirolimus—FGF2—Immune System—IL5—allergic rhinitis	7.51e-05	0.00168	CbGpPWpGaD
Sirolimus—Rash—Hydrocortisone—allergic rhinitis	7.47e-05	0.000242	CcSEcCtD
Sirolimus—Dermatitis—Hydrocortisone—allergic rhinitis	7.47e-05	0.000242	CcSEcCtD
Sirolimus—FGF2—Signaling Pathways—CYSLTR1—allergic rhinitis	7.44e-05	0.00167	CbGpPWpGaD
Sirolimus—Headache—Hydrocortisone—allergic rhinitis	7.42e-05	0.000241	CcSEcCtD
Sirolimus—Dizziness—Triamcinolone—allergic rhinitis	7.38e-05	0.000239	CcSEcCtD
Sirolimus—Dizziness—Methylprednisolone—allergic rhinitis	7.36e-05	0.000239	CcSEcCtD
Sirolimus—Asthenia—Dexamethasone—allergic rhinitis	7.26e-05	0.000236	CcSEcCtD
Sirolimus—Asthenia—Betamethasone—allergic rhinitis	7.26e-05	0.000236	CcSEcCtD
Sirolimus—Nausea—Prednisolone—allergic rhinitis	7.21e-05	0.000234	CcSEcCtD
Sirolimus—FGF2—Signaling Pathways—CCL11—allergic rhinitis	7.19e-05	0.00161	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—TGFB1—allergic rhinitis	7.18e-05	0.00161	CbGpPWpGaD
Sirolimus—Pruritus—Betamethasone—allergic rhinitis	7.16e-05	0.000232	CcSEcCtD
Sirolimus—Pruritus—Dexamethasone—allergic rhinitis	7.16e-05	0.000232	CcSEcCtD
Sirolimus—MTOR—Adaptive Immune System—HLA-DQB1—allergic rhinitis	7.11e-05	0.00159	CbGpPWpGaD
Sirolimus—Vomiting—Triamcinolone—allergic rhinitis	7.1e-05	0.00023	CcSEcCtD
Sirolimus—Vomiting—Methylprednisolone—allergic rhinitis	7.08e-05	0.00023	CcSEcCtD
Sirolimus—Nausea—Hydrocortisone—allergic rhinitis	7.04e-05	0.000228	CcSEcCtD
Sirolimus—MTOR—Signaling Pathways—PTGDR2—allergic rhinitis	7.04e-05	0.00158	CbGpPWpGaD
Sirolimus—Rash—Triamcinolone—allergic rhinitis	7.04e-05	0.000228	CcSEcCtD
Sirolimus—Dermatitis—Triamcinolone—allergic rhinitis	7.03e-05	0.000228	CcSEcCtD
Sirolimus—Rash—Methylprednisolone—allergic rhinitis	7.02e-05	0.000228	CcSEcCtD
Sirolimus—Dermatitis—Methylprednisolone—allergic rhinitis	7.01e-05	0.000227	CcSEcCtD
Sirolimus—FGF2—Adaptive Immune System—ICAM1—allergic rhinitis	6.99e-05	0.00157	CbGpPWpGaD
Sirolimus—Headache—Triamcinolone—allergic rhinitis	6.99e-05	0.000227	CcSEcCtD
Sirolimus—Headache—Methylprednisolone—allergic rhinitis	6.98e-05	0.000226	CcSEcCtD
Sirolimus—Diarrhoea—Dexamethasone—allergic rhinitis	6.93e-05	0.000225	CcSEcCtD
Sirolimus—Diarrhoea—Betamethasone—allergic rhinitis	6.93e-05	0.000225	CcSEcCtD
Sirolimus—MTOR—Immune System—HLA-G—allergic rhinitis	6.91e-05	0.00155	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TAC1—allergic rhinitis	6.89e-05	0.00154	CbGpPWpGaD
Sirolimus—Dizziness—Betamethasone—allergic rhinitis	6.7e-05	0.000217	CcSEcCtD
Sirolimus—Dizziness—Dexamethasone—allergic rhinitis	6.7e-05	0.000217	CcSEcCtD
Sirolimus—Nausea—Triamcinolone—allergic rhinitis	6.63e-05	0.000215	CcSEcCtD
Sirolimus—Nausea—Methylprednisolone—allergic rhinitis	6.61e-05	0.000214	CcSEcCtD
Sirolimus—Vomiting—Dexamethasone—allergic rhinitis	6.44e-05	0.000209	CcSEcCtD
Sirolimus—Vomiting—Betamethasone—allergic rhinitis	6.44e-05	0.000209	CcSEcCtD
Sirolimus—FKBP1A—Disease—SMAD3—allergic rhinitis	6.44e-05	0.00144	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL5—allergic rhinitis	6.41e-05	0.00144	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—NFKB1—allergic rhinitis	6.4e-05	0.00143	CbGpPWpGaD
Sirolimus—Rash—Dexamethasone—allergic rhinitis	6.38e-05	0.000207	CcSEcCtD
Sirolimus—Rash—Betamethasone—allergic rhinitis	6.38e-05	0.000207	CcSEcCtD
Sirolimus—Dermatitis—Dexamethasone—allergic rhinitis	6.38e-05	0.000207	CcSEcCtD
Sirolimus—Dermatitis—Betamethasone—allergic rhinitis	6.38e-05	0.000207	CcSEcCtD
Sirolimus—Headache—Dexamethasone—allergic rhinitis	6.34e-05	0.000206	CcSEcCtD
Sirolimus—Headache—Betamethasone—allergic rhinitis	6.34e-05	0.000206	CcSEcCtD
Sirolimus—EIF4E—Signaling Pathways—SMAD3—allergic rhinitis	6.15e-05	0.00138	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	6.02e-05	0.00135	CbGpPWpGaD
Sirolimus—Nausea—Dexamethasone—allergic rhinitis	6.01e-05	0.000195	CcSEcCtD
Sirolimus—Nausea—Betamethasone—allergic rhinitis	6.01e-05	0.000195	CcSEcCtD
Sirolimus—MTOR—Signaling by NGF—NFKB1—allergic rhinitis	6e-05	0.00134	CbGpPWpGaD
Sirolimus—FGF2—Immune System—HLA-DQB1—allergic rhinitis	5.81e-05	0.0013	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CD4—allergic rhinitis	5.61e-05	0.00126	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL5—allergic rhinitis	5.57e-05	0.00125	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CYSLTR1—allergic rhinitis	5.52e-05	0.00124	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CD4—allergic rhinitis	5.35e-05	0.0012	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL11—allergic rhinitis	5.33e-05	0.0012	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—NFKB1—allergic rhinitis	5.22e-05	0.00117	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TAC1—allergic rhinitis	5.22e-05	0.00117	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—ICAM1—allergic rhinitis	5.19e-05	0.00116	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CD4—allergic rhinitis	5.14e-05	0.00115	CbGpPWpGaD
Sirolimus—FGF2—Disease—SMAD3—allergic rhinitis	4.88e-05	0.00109	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL5—allergic rhinitis	4.85e-05	0.00109	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—NFKB1—allergic rhinitis	4.83e-05	0.00108	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—NFKB1—allergic rhinitis	4.61e-05	0.00103	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SMAD3—allergic rhinitis	4.51e-05	0.00101	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—NFKB1—allergic rhinitis	4.43e-05	0.000993	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TGFB1—allergic rhinitis	4.35e-05	0.000975	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-DQB1—allergic rhinitis	4.31e-05	0.000967	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ICAM1—allergic rhinitis	4.24e-05	0.000951	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CD4—allergic rhinitis	3.97e-05	0.00089	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TAC1—allergic rhinitis	3.87e-05	0.000869	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD4—allergic rhinitis	3.81e-05	0.000855	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CD4—allergic rhinitis	3.8e-05	0.000851	CbGpPWpGaD
Sirolimus—MTOR—Disease—SMAD3—allergic rhinitis	3.62e-05	0.000812	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL5—allergic rhinitis	3.6e-05	0.000807	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	3.57e-05	0.0008	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—NFKB1—allergic rhinitis	3.42e-05	0.000767	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SMAD3—allergic rhinitis	3.42e-05	0.000766	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—NFKB1—allergic rhinitis	3.29e-05	0.000737	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ICAM1—allergic rhinitis	3.15e-05	0.000706	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NFKB1—allergic rhinitis	3.12e-05	0.0007	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD4—allergic rhinitis	3.12e-05	0.000699	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.97e-05	0.000666	CbGpPWpGaD
Sirolimus—FGF2—Disease—CD4—allergic rhinitis	2.88e-05	0.000645	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFB1—allergic rhinitis	2.73e-05	0.000611	CbGpPWpGaD
Sirolimus—FGF2—Immune System—NFKB1—allergic rhinitis	2.69e-05	0.000602	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFB1—allergic rhinitis	2.6e-05	0.000583	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SMAD3—allergic rhinitis	2.54e-05	0.000568	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD4—allergic rhinitis	2.31e-05	0.000519	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NFKB1—allergic rhinitis	2.29e-05	0.000514	CbGpPWpGaD
Sirolimus—MTOR—Disease—CD4—allergic rhinitis	2.14e-05	0.000479	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFB1—allergic rhinitis	2.07e-05	0.000463	CbGpPWpGaD
Sirolimus—MTOR—Immune System—NFKB1—allergic rhinitis	1.99e-05	0.000447	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFB1—allergic rhinitis	1.91e-05	0.000428	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NFKB1—allergic rhinitis	1.74e-05	0.000389	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFB1—allergic rhinitis	1.53e-05	0.000344	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFB1—allergic rhinitis	1.45e-05	0.000324	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NFKB1—allergic rhinitis	1.29e-05	0.000289	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFB1—allergic rhinitis	1.07e-05	0.000241	CbGpPWpGaD
